Metraipolis › archive › dc_c03da7febad8
What role for real-world evidence in market access of biosimilars? — Europe PMC PMID:40066332
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40066332
- DOI
- 10.3389/fphar.2025.1538866
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-06T16:03:29.935Z
- SHA-256 of the archived text
990c640da3bd67d45e4e01fee44c3d557a7f61fc9fb6c575b26a7d17148c5155- Stable URL of this page
https://metraipolis.com/documento/dc_c03da7febad8
How to cite
What role for real-world evidence in market access of biosimilars? — Europe PMC PMID:40066332 — Europe PMC (en), https://europepmc.org/article/MED/40066332 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c03da7febad8 (Metraipolis archive dc_c03da7febad8, sha256 990c640da3bd67d45e4e01fee44c3d557a7f61fc9fb6c575b26a7d17148c5155)
BibTeX
@misc{dcc03da7febad8,
title = {What role for real-world evidence in market access of biosimilars? — Europe PMC PMID:40066332},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40066332},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c03da7febad8; sha256 990c640da3bd67d45e4e01fee44c3d557a7f61fc9fb6c575b26a7d17148c5155},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40066332. Agents can read the archived copy with the MCP tool read_document.